About me
Silvia Hannaman currently serves as Vice President & General Manager of the Endocrinology Franchise at Neurocrine Biosciences. She is responsible for strategy and leading the sales, marketing, and omnichannel engagement teams in support of a rare, endocrine program.
Silvia joined Neurocrine in 2014, serving as part of the commercial leadership team that built Neurocrine’s commercial capabilities and in various roles through marketing and commercial development. In 2017, she led the successful launch of a novel therapy for Tardive Dyskinesia and Huntington’s Chorea.
Silvia has spent nearly 30 years in the medical device and pharmaceutical industries with organizations such as J&J, Edwards Lifesciences, and Santarus, in a variety of development and commercial roles. She holds a BS in biochemistry and cell biology from UCSD and an MBA in marketing and operations from USC Marshall School of Business.
